BEND, Ore., Oct. 21 /Xinhua-PRNewswire/ -- Bend Research Inc. announced today that it will independently offer unique drug-delivery expertise and technologies to outside firms in the pharmaceutical and biotechnology industries.
Bend Research will continue its 23-year collaboration with Pfizer but will also be free to work with outside firms using proprietary technologies developed jointly by the two firms.
These technologies include the spray-dried dispersion (SDD) technology (which increases the oral bioavailability of low-solubility compounds), controlled-release, multiparticulate, and pulmonary delivery platforms.
Bend Research CEO Rod Ray commented: "Our work with Pfizer has helped us tremendously to grow and develop our capabilities over the past two decades. In return, we have helped Pfizer advance a significant number of their compounds. Today, we’re pleased to have the opportunity to collaborate with additional clients to enable the delivery of new medicines."
Kelvin Cooper, Senior Vice President of Worldwide Pharmaceutical Sciences for Pfizer Global Research and Development, agreed: "Our collaboration with Bend Research has proved to be valuable and we look forward to continued work with Bend Research. Through this agreement, we hope the technologies we’ve developed together will help speed the introduction of new medicines to patients throughout the world."
Under terms of the agreement with Pfizer, Bend Research will have the ability to employ expertise and processes developed with Pfizer to benefit other drug developers. These include optimized drug discovery, dosage form development, engineering capabilities, and manufacture of supplies for clinical trials under Good Manufacturing Practice (GMP) conditions.
Bend Research will continue to work exclusively with Pfizer on certain specific technology platforms. This commitment reaffirms the strong relationship between the two companies while providing enabling technologies for improved world health
About Bend Research Inc.
Bend Research Inc. is an interdisciplinary technology-, science-, and engineering-driven company that discovers, advances, develops, and commercializes pharmaceutical and healthcare products through the application of technology platforms. This capability is driven by scientific and engineering excellence. The company has three facilities based in Bend, Oregon.
